Lymphangioleiomyomatosis: what do we know and what are we looking for?

Harari S., Torre O., Moss J.

Source: Eur Respir Rev 2011; 20: 34-44

Journal Issue: March 2011 - 20 (119)

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Harari S., Torre O., Moss J.. Lymphangioleiomyomatosis: what do we know and what are we looking for?. Eur Respir Rev 2011; 20: 34-44

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Lymphangioleiomyomatosis Source: Eur Respir J 2006; 27: 1056-1065 Year: 2006
Alk-rearranged adenocarcinoma arising in lung lymphangioleiomyomatosis of a patient with tuberous sclerosis complex Source: International Congress 2019 – Lung cancer? Year: 2019
The changing face of a rare disease: lymphangioleiomyomatosis Source: Eur Respir J 2015; 46: 1471-1485 Year: 2015
Natural history of incidental sporadic or tuberous sclerosis complex associated lymphangioleiomyomatosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019
Tuberous sclerosis complex (TSC) with pulmonary involvement - a retrospective review of 4 cases Source: Eur Respir J 2002; 20: Suppl. 38, 448s Year: 2002
Hemoptysis: rare pulmonary manifestation of tuberous sclerosis in childhood Source: Eur Respir J 2006; 28: Suppl. 50, 544s Year: 2006
Pulmonary function tests for lymphangioleiomyomatosis screening in women with tuberous sclerosis complex Source: International Congress 2016 – Orphan diseases I Year: 2016
Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis Source: Eur Respir J 2008; 31: 678-680 Year: 2008
LAM: lymphangioleiomyomatosis Source: Breathe 2014; 10:331-332 Year: 2014
Sarcoidosis and tuberculosis: A rare combination? Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Rate of FEV1 decline in lymphangioleiomyomatosis associated with tuberous sclerosis complex Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012
Should patients with lymphangioleiomyomatosis undergo screening for meningioma? Source: Eur Respir J 2004; 24 : 888-889 Year: 2004
Interstitial lung disease in systemic sclerosis: where do we stand? Source: Eur Respir Rev 2015; 24: 411-419 Year: 2015
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis Source: Eur Respir Rev 2012 21:196-206 Year: 2012
Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean? Source: Eur Respir J, 55 (6) 2000894; 10.1183/13993003.00894-2020 Year: 2020
Severity and outcome of cystic lung disease in women with tuberous sclerosis complex Source: Eur Respir J 2015; 45: 171-180 Year: 2015
Multiple cystic lung diseases Source: Eur Respir Mon 2011; 54: 46-83 Year: 2011
Cysts and systemic findings: think about rare diseases Source: Virtual Congress 2021 – CCC Interstitial lung diseases Year: 2021
Lymphangioleiomyomatosis (LAM) Source: Breathe 2017; 13: 64 Year: 2017
Lymphangioleiomyomatosis (LAM) initially presented as retroperitoneal tumour. Two case reports Source: Eur Respir J 2005; 26: Suppl. 49, 83s Year: 2005